Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study

28 August 2021 (20:33 - 20:42)
Organised by:
Congress Presentation Part of: Highlights from the Young in coronary artery disease Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience